Harvard Bioscience financial statements

하버드 바이오사이언스NASDAQ:HBIO · Nasdaq · Healthcare · sector #17
$8.50-0.70%
2026-10-07 close

Harvard Bioscience's published financial data is dated 2026-10-04. 2024 revenue was $94M. 2024 operating profit was −$6M.

Reported results

Harvard Bioscience notifications

Quantus Signal · live data · not investment advice · Privacy Policy